| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9021955 | International Congress Series | 2005 | 4 Pages |
Abstract
In premenopausal women, with a desire for future childbearing, progestogen based reversion of hyperplasia, and even early cancer, can be obtained in a substantial proportion of patients. In the future, new anti-estrogens like fulvestrant could play a role in the non-surgical treatment of endometrial cancer, in those situations where surgery is precluded.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
P. Kenemans, R.A. Verstraeten,